Severe thrombocytopenia can be very dangerous, even fatal, without treatment. Treatment depends on the underlying cause but can include medications, transfusions, and surgery. Severe thrombocytopenia ...

Immune thrombocytopenia (ITP) is an autoimmune disorder characterised by both antibody-mediated platelet destruction and impaired megakaryocyte function. This results in decreased platelet counts and ...

— NDA is supported by data from successful Phase III ESLIM-01 trial in patients with adult primary immune thrombocytopenia who have received at least one previous therapy — The NMPA granted ...

Close monitoring via weekly complete blood counts (CBCs) for the first 2 months is essential to mitigate risks, according to Zeidan. Supportive care such as platelet transfusions or growth factors may ...

Isolated thrombocytopenia is a condition where your platelet levels are low, but other blood cell levels are within a typical range. It’s rare and potentially dangerous. Thrombocytopenia is also known ...

Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Design by Avery Nelson. Buy this photo. In a recent University of Michigan study, researchers ...

InnoCare Pharma, a leading biopharmaceutical company, announced today that the first patient has been dosed in Phase II clinical trial of its Bruton’s tyrosine kinase (BTK) inhibitor orelabrutinib for ...

SAN FRANCISCO (MarketWatch) -- MGI Pharma Inc. mogn said late Tuesday it has agreed to acquire the development rights to AKR-501, a molecule being developed for the treatment of thrombocytopenia, from ...

“Doptelet represents a significant advancement in the treatment of children and adolescents with persistent or chronic ITP,” said Rachael Grace, MD, MMSc, Pediatric Hematologist and Director, ...